Barclays 28th Annual Global Healthcare Conference March 12, 2026 8:30 AM EDTCompany ParticipantsAmy Parison - Senior VP ...

WEST LAFAYETTE, Ind. — Consumers, businesses and institutions may soon have private, secure and trustworthy generative AI tools for editing and sharing profile photos, ID images and personal pictures ...

Genome editing-based therapies typically aim to treat disease by correcting underlying genetic mutations in patient's cells.

The U.S. Food and Drug Administration approved the first cell-based gene therapies for sickle cell disease, including the ...

The cost of sequencing a human genome has fallen from $100 million in 2001 to around $1,000 today—dropping even faster than Moore’s Law predicted. At the center of this revolution is CRISPR, a ...

A version of this Priestley Medal address will be presented at the American Chemical Society Spring 2026 meeting ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A St. Louis startup is turning ...

Researchers from Japan have established a new in vivo genome-editing system, CRISPR–Cas3, as a promising therapeutic approach for ATTR Genetic disorders occur due to alterations in the primary genetic ...

The advent of genetics, molecular biology, and genome sequencing has rapidly accelerated the development of elite genetic lines across various species, including poultry. It is now possible to ...

Behind every scientific breakthrough at Colossal Biosciences stands a question that transcends technology: Should we? While genetic engineering capabilities have advanced dramatically, the ethical ...